Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Allakos Inc
(NQ:
ALLK
)
1.280
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
111
Open
1.280
Bid (Size)
1.280 (15)
Ask (Size)
1.320 (82)
Prev. Close
1.280
Today's Range
1.280 - 1.280
52wk Range
1.000 - 5.640
Shares Outstanding
86,560,315
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023
March 14, 2024
ALLK stock results show that Allakos missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Allakos Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 14, 2024
From
Allakos Inc.
Via
GlobeNewswire
Performance
YTD
-53.28%
-53.28%
1 Month
-12.33%
-12.33%
3 Month
-53.28%
-53.28%
6 Month
-48.80%
-48.80%
1 Year
-71.17%
-71.17%
More News
Read More
Allakos Presents Preclinical Data Highlighting Inhibition of MRGPRX2-Mediated Mast Cell Activation with AK006 at AAAAI 2024
February 26, 2024
From
Allakos Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 14, 2024
Via
Benzinga
Where Allakos Stands With Analysts
December 18, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Allakos
November 28, 2023
Via
Benzinga
Why Shares of Allakos Are Up Wednesday
September 27, 2023
Via
The Motley Fool
Allakos Announces Publication Highlighting AK006 Mast Cell Inhibition
February 12, 2024
From
Allakos Inc.
Via
GlobeNewswire
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
January 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 17, 2024
Via
Benzinga
Gold Down 1%; PNC Financial Posts Upbeat Earnings
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 16, 2024
Via
Benzinga
Crude Oil Edges Lower; Morgan Stanley Posts Upbeat Revenue
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Allakos (ALLK) Stock Down 57% Today?
January 16, 2024
Via
InvestorPlace
Trial Setback: Allakos Drops Lead Skin Disorder Candidate, Cuts Workforce By 50%
January 16, 2024
Via
Benzinga
Dow Dips 200 Points; Goldman Sachs Earnings Top Views
January 16, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 16, 2024
Via
Benzinga
Allakos Announces a Restructuring to Focus on Development of AK006
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
January 16, 2024
From
Allakos Inc.
Via
GlobeNewswire
Allakos Analyst Turns Bullish, Sees 'Significant Upside' If Study Results Are Positive
December 18, 2023
Via
Benzinga
Allakos Provides Business Update and Reports Third Quarter 2023 Financial Results
November 13, 2023
From
Allakos Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 09, 2023
Via
InvestorPlace
Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside
September 27, 2023
Via
Benzinga
Why Matrix Service Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
September 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
September 27, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.